TY - JOUR
T1 - V600EBRAF is associated with disabled feedback inhibition of RAF-MEK signaling and elevated transcriptional output of the pathway
AU - Pratilas, Christine A.
AU - Taylor, Barry S.
AU - Ye, Qing
AU - Viale, Agnes
AU - Sander, Chris
AU - Solit, David B.
AU - Rosen, Neal
PY - 2009/3/17
Y1 - 2009/3/17
N2 - Tumors with mutant BRAF and those with receptor tyrosine kinase (RTK) activation have similar levels of phosphorylated ERK, but only the former depend on ERK signaling for proliferation. The mitogen-activated protein kinase, extracellular signal-regulated kinase kinase (MEK)/ERK-dependent transcriptional output was defined as the genes whose expression changes significantly 8 h after MEK inhibition. In V600EBRAF cells, this output is comprised of 52 genes, including transcription factors that regulate transformation and members of the dual specificity phosphatase and Sprouty gene families, feedback inhibitors of ERK signaling. No such genes were identified in RTK tumor cells, suggesting that ERK pathway signaling output is selectively activated in BRAF mutant tumors. We find that RAF signaling is feedback down-regulated in RTK cells, but is insensitive to this feedback in BRAF mutant tumors. Physiologic feedback inhibition of RAF/MEK signaling down-regulates ERK output in RTK cells; evasion of this feedback in mutant BRAF cells is associated with increased transcriptional output and MEK/ ERK-dependent transformation.
AB - Tumors with mutant BRAF and those with receptor tyrosine kinase (RTK) activation have similar levels of phosphorylated ERK, but only the former depend on ERK signaling for proliferation. The mitogen-activated protein kinase, extracellular signal-regulated kinase kinase (MEK)/ERK-dependent transcriptional output was defined as the genes whose expression changes significantly 8 h after MEK inhibition. In V600EBRAF cells, this output is comprised of 52 genes, including transcription factors that regulate transformation and members of the dual specificity phosphatase and Sprouty gene families, feedback inhibitors of ERK signaling. No such genes were identified in RTK tumor cells, suggesting that ERK pathway signaling output is selectively activated in BRAF mutant tumors. We find that RAF signaling is feedback down-regulated in RTK cells, but is insensitive to this feedback in BRAF mutant tumors. Physiologic feedback inhibition of RAF/MEK signaling down-regulates ERK output in RTK cells; evasion of this feedback in mutant BRAF cells is associated with increased transcriptional output and MEK/ ERK-dependent transformation.
KW - Braf mutation
KW - Dual specificity phosphatase
KW - Extracellular signal-regulated kinase kinase inhibition
KW - Mitogen-activated protein kinase
UR - http://www.scopus.com/inward/record.url?scp=63149194964&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=63149194964&partnerID=8YFLogxK
U2 - 10.1073/pnas.0900780106
DO - 10.1073/pnas.0900780106
M3 - Article
C2 - 19251651
AN - SCOPUS:63149194964
SN - 0027-8424
VL - 106
SP - 4519
EP - 4524
JO - Proceedings of the National Academy of Sciences of the United States of America
JF - Proceedings of the National Academy of Sciences of the United States of America
IS - 11
ER -